Na+-to-sugar stoichiometry of SGLT3

Ana Díez-Sampedro, Sepehr Eskandari, Ernest M. Wright, and Bruce A. Hirayama

Department of Physiology, University of California Los Angeles, School of Medicine, Los Angeles, California 90095-1751


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Sodium-glucose cotransporters (SGLTs) mediate active transport of sugar across cell membranes coupled to Na+, by using the electrochemical gradient as a driving force. In the kidney, there is evidence for two kinds of cotransporters, a high-affinity, low-capacity system, and a low-affinity, high-capacity system, with differences in substrate specificity and kinetics. Three renal SGLT clones have been identified: SGLT1 corresponding to the high-affinity system, and SGLT2 and SGLT3 with properties reminiscent of the low-affinity system. We have determined the stoichiometry of pig SGLT3 (pSGLT3) by using a direct method, comparing the substrate-induced inward charge to 22Na or [14C]alpha -methyl-D-glucopyranoside uptake in the same oocyte. pSGLT3 stoichiometry is 2 Na+:1 sugar, the same as that for SGLT1, but different from SGLT2 (1:1). The Na+ Hill coefficient for SGLT3 is ~1.5, suggesting low cooperativity between Na+ binding sites. Thus SGLT3 has functional characteristics intermediate between SGLT1 and SGLT2, so, whereas SGLT3 stoichiometry is the same as that for SGLT1 (2:1), sugar affinity and specificity are similar to SGLT2.

sodium-glucose cotransporter; electrophysiology; ion-substrate coupling


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

SODIUM-DEPENDENT GLUCOSE COTRANSPORTERS (SGLTs) mediate the "active" transport of glucose across the brush border membranes of renal and intestinal epithelia by using the Na+ electrochemical gradient across the membrane as a driving force. It has been commonly accepted that there is a single high-affinity cotransporter in the intestine and two cotransporters in the proximal renal tubule, a low-affinity, high-capacity SGLT in the convoluted tubule, and a high-affinity, low-capacity SGLT in the straight tubule (1). There is compelling evidence that SGLT1 is the high-affinity transporter expressed in both the intestine and straight proximal tubule (6, 19, 23), but there is some ambiguity about the gene coding for the major renal SGLT (commonly referred to as SGLT2).

So far, two SGLTs have been cloned from renal tissue, and there are at least six other SGLT family members expressed in the kidney whose functions are unknown. The first SGLT to be cloned from rat and human kidney was SGLT2 (28, 29). Although poorly expressed in heterologous systems, its function resembles those traditionally attributed to the transporter in the rabbit proximal renal tubule, i.e., low affinity for sugars, highly selective for glucose over galactose, and, on the basis of indirect experiments, a Na+-to-sugar stoichiometry of 1:1 (12, 28, 29). Furthermore, in the intact rat kidney, the distribution of SGLT2 mRNA mirrors that expected for the high-capacity cotransporter (29). The second renal SGLT to be identified was a clone originally thought to be a neutral amino acid transporter and called SAAT1 (13). This pig clone was later expressed in Xenopus laevis oocytes, permitting functional characterization with a high degree of precision, and it was found that SAAT1 was a low-affinity Na+/sugar cotransporter (15, 16). This transporter was called pig SGLT2 (pSGLT2) and renamed as SGLT3 (3) after the cloning of the human ortholog (4).

In common with SGLT2, SGLT3 has a low affinity for sugars, and is highly selective for D-glucose; i.e., unlike SGLT1 it has a very low affinity for D-galactose and 3-O-methyl-D-glucopyranoside (3OMDG) apparent affinity [(K0.5)>> 20 mM; 3, 16]. A major difference between SGLT3 and SGLT2 is that SGLT2 has a high affinity for Na+ under the same sugar concentration (2 mM) (12, 15).

In Na+-coupled cotransporters, a knowledge of the ion-substrate coupling stoichiometry is important because it reveals insights into the concentrative capacity of the transport system under investigation. The higher the degree of coupling (one or more Na+ per substrate), the greater the substrate concentration that can be achieved in the cell by the transporter, and this becomes particularly critical when large concentration gradients need to be overcome. On the basis of analysis of the Na+ Hill coefficient it was suggested that the SGLT3 coupling was 1 Na+:1 sugar (15). In this work, we have directly determined the ion-substrate coupling stoichiometry of SGLT3 by using radioactive tracer uptakes into voltage-clamped oocytes (14).


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In our experiments, we made a direct determination of Na+-to-sugar-coupling stoichiometry and also investigated the ion-protein binding interaction of SGLT3. The cloned pSGLT3 (SAAT1) protein was functionally expressed in X. laevis oocytes. For all experiments the membrane potential was controlled and sugar-induced currents were measured by using the two electrode voltage-clamp technique. Our experimental strategy was first to directly compare unidirectional ligand uptakes (22Na+ or [14C]alpha -methyl-D-glucopyranoside; alpha -MDG) into voltage-clamped cells to the cotransporter currents over the same time course in single cells (14), and second to determine the Na+ activation of cotransport for a Hill analysis.

Oocytes expressing pSGLT3. Stage VI oocytes from X. laevis (Nasco, Fort Atkinson, WI) were defolliculated and injected with pSGLT3 cRNA (pSAAT1, 13,16) and maintained at 18°C in modified Barth's medium (21) containing gentamycin (5 mg/ml) and penicillin (100 units/ml)/streptomycin (100 µg/ml). Experiments were performed at 22 ± 1°C, 5-15 days after the injection.

The oocyte was placed in the chamber, impaled with electrodes, and continuously superfused with the required medium. Na+ medium contained (in mM) 100 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2, and 10 HEPES (pH 7.5 with Tris). In Na+-activation experiments, where the Na+ concentration was changed, ionic strength and chloride concentration were maintained by replacing NaCl with choline chloride.

Hill analysis. Na+ activation experiments were carried out at 11 different voltages (from -150 to +50 mV). The oocyte was bathed in a Na+ solution, its concentration varying from 50 µM to 10 mM. At each Na+ concentration, sugar-dependent currents were measured with 3, 25, or 100 mM alpha -MDG. At each voltage the data were fitted to Eq. 1
<FR><NU>I<SUP>&agr;-MDG</SUP></NU><DE><IT>I</IT><SUP>&agr;-MDG</SUP><SUB>max</SUB></DE></FR><IT>=</IT><FR><NU>[S]<SUP><IT>n</IT></SUP></NU><DE>[S]<SUP><IT>n</IT></SUP><IT>+</IT>(<IT>K</IT><SUP>S</SUP><SUB>0.5</SUB>)<SUP><IT>n</IT></SUP></DE></FR> (1)
where Ialpha -MDG is the alpha -MDG-induced steady-state current, Imaxalpha -MDG is the predicted maximum current, [S] is the substrate concentration (Na+ or alpha -MDG), the half-saturation constant for sodium (K0.5S) is the substrate concentration at half-maximal current (Imax), and n is the Hill coefficient. The data are presented as means ± SE.

Charge-to-Na+ stoichiometry. Uptake of 22Na was optimized for specific activity and transport rate by using a saturating concentration of alpha -MDG (100 mM) and a 22Na concentration of 3 or 10 mM (>2 times the Na+ K0.5; see below). The voltage-clamped oocyte (at -50 or -100 mV) was superfused with 3 mM (or 10 mM) Na+ solution. A stable baseline current was recorded, and then the bath solution was changed to 100 mM alpha -MDG with 3 mM (or 10 mM) 22Na solution (2.2-4.5 µCi/ml) for 2-10 min. The solution was changed back to the Na+ medium until the current returned to baseline (see Fig. 2). The oocyte was recovered from the chamber, rinsed three times in ice-cold choline medium (5 ml each) and solubilized with 10% SDS for liquid scintillation counting.

The charge associated with the 22Na uptake induced by alpha -MDG was the difference between baseline and alpha -MDG current only while 22Na was present. Net charge transported into the oocyte was obtained by integrating the inward current produced by the sugar uptake in the oocyte. Charge was converted to its molar equivalent by using Faraday's constant. For controls, we measured the current and 22Na uptake in pSGLT3-expressing oocytes in the absence of sugar.

Charge-to-sugar stoichiometry. The oocyte was clamped at -100 mV and superfused with 100 mM Na+ solution. When the baseline was stable, 0.5, 1, or 2 mM [14C]alpha -MDG was added to the Na+ solution. After 10 min the sugar was removed from the bathing solution, and the current was returned to the baseline. The oocyte was washed, solubilized, and counted as described above. Sugar-induced current was obtained as the difference between baseline and the alpha -MDG current. The [14C]alpha -MDG uptakes were optimized by using a sugar concentration close to the sugar K0.5 (2 mM) at a high Na+ concentration, 100 mM. [14C]alpha -MDG uptake in noninjected oocytes was used to correct for endogenous alpha -MDG uptake. The current was converted to its molar equivalent as described above.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Na+ activation kinetics. The Hill equation is often used as an indirect method to estimate substrate coupling ratios of transporters. In pSGLT3-expressing oocytes, the steady-state dose-response activation curve for Na+ was fitted to the Hill equation. Figure 1 is an example of the data for one sugar concentration and its fit to the Hill equation. The Hill coefficient (n) at -90 mV was 1.5 ± 0.1. alpha -MDG concentration was 25 mM, and the Na+ concentration varied between 50 µM and 10 mM. The n was independent of the sugar concentration (from 3 to 100 mM) and membrane potential (from -10 to -150 mV) and ranged between 1.3 and 1.8 (mean = 1.6 ± 0.03, n = 18). The K0.5 and Imax at each voltage and sugar concentration were consistent with the previously published values (15).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   Na+ activation at -90 mV in a sodium-glucose cotransporter (SGLT3)-expressing oocyte. Current was induced by 25 mM alpha -methyl-D-glucopyranoside (alpha -MDG) at different Na concentrations ([Na+]). Dotted line is the fit of data to Eq. 1, yielding a Hill coefficient (n) of 1.5 ± 0.1. The half-saturation constant for sodium (K0.5) was 1.7 mM, and the maximal current (Imax) for Na+ was 212 nA.

Charge transfer and alpha -MDG uptake are linearly correlated (2:1). Figure 2 shows the sugar-dependent current in an oocyte-expressing pSGLT3 clamped at -100 mV. Initially, the oocyte was superfused with 100 mM Na+ solution, and the addition of 2 mM [14C]alpha -MDG induced an inward current of ~330 nA. When sugar was removed from the bath, the current returned to the baseline. The current was integrated with time to determine the sugar-dependent net charge influx (Qalpha -MDG). This charge was converted to its molar equivalent and compared with the sugar ([14C]alpha -MDG) uptake measured in this same oocyte. The inward charge transported was 1.7 × 10-4 C of positive charge, which corresponds to 1.77 nmol, and sugar uptake was 0.8 nmol, resulting in a charge-to-sugar ratio for this oocyte of 2.2:1. The same process was repeated with 12 oocytes and [14C]alpha -MDG concentrations of 0.5, 1, or 2 mM. All the data could be fitted to a single regression line, indicating that the stoichiometry was independent of the sugar concentration. For all oocytes tested, the value of Qalpha -MDG/alpha -MDG uptake was 2.2 ± 0.1 (Fig. 3).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 2.   Representative [14C]alpha -MDG-induced inward current in an SGLT3 expressing oocyte. Two millimolar alpha -MDG (in 100 mM Na) uptake was measured for 10 min at a membrane potential of -100 mV. When the sugar was added to the bath, the inward current increased to ~300 nA. After 10 min, the sugar was removed from the bath and the current returned to baseline. The transported charge is the integral of the sugar-dependent current. Q, net charge transported.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 3.   Charge-to-sugar stochiometry for SGLT3. Na+ concentration was 100 mM, alpha -MDG concentration was 0.5, 1, or 2 mM, and the exposure to sugar was 10 min. The membrane potential was held at -100 mV. Each point corresponds to 1 oocyte, and the alpha -MDG uptake of control oocytes has been subtracted. The data were fit to a linear regression with a slope of 2.2 ± 0.1 charges/alpha -MDG. Qalpha -MDG, sugar-dependent net charge influx.

Charge transfer and Na+ uptake are linearly correlated (1:1). The relationship between charge influx and 22Na uptake was measured in 11 oocytes clamped at -50 or -100 mV. Each oocyte was bathed in 3 or 10 mM 22Na solution and, after stable baseline, 100 mM alpha -MDG was added. The sugar-dependent inward current was recorded, and 22Na uptake was measured in the same oocyte. Figure 4 shows the relationship between the net charge transported (Q) and the radiolabeled Na+ uptake. The QNa/Na+ uptake ratio was independent of voltage and Na+ concentration. All data were fitted to a regression line with a slope of 1.2 ± 0.1. Open circles represent the sugar-independent Na uptake (zero current), obtained from six pSGLT3-expressing oocytes in experiments carried out in the absence of sugar (indistinguishable from 22Na uptake in noninjected oocytes).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 4.   Charge-to-Na stochiometry for SGLT3. The sugar-dependent 22Na uptake and sugar-dependent current were simultaneously measured in oocytes expressing SGLT3. The Na+ concentration was 3 or 10 mM, and the alpha -MDG concentration was 100 mM. The membrane potential was held at -50 or -100 mV. Each point represents a single oocyte. Sugar-independent 22Na uptake was measured in 6 SGLT3-expressing oocytes (0 current). The data were fit to a linear regression with a slope of 1.2 ± 0.1 charges/Na+.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

There have been three SGLT genes identified in the human genome: SGLT1 (9) and SGLT3 (4) on human chromosome 22 and SGLT2 (27) on chromosome 16. They are functionally distinct, having different sugar specificities and, as we have determined in this paper, different Na+/sugar coupling ratios. The SGLT3 stoichiometry is 2 Na+:1 sugar, identical to that of SLGT1 (14), but different from the 1 Na+:1 sugar stoichiometry of SGLT2 (12, 29).

We used the fact that transport of sugar by SGLT3 generates an electrical current (Fig. 2), indicating that a positive ion is transported into the cell with sugar, to normalize our data. We correlated uptake of both sugar and Na+ to the translocated charge by using simultaneous electrophysiological measurements and unidirectional radioactive tracer fluxes (14). These measurements indicated that 1.2 ± 0.1 net inward positive charges were transported for every Na ion cotransported (Fig. 4), verifying that the sugar-dependent current is carried by Na ions. In comparison, 2.2 ± 0.1 inward charges were generated for each sugar transported (Fig. 3), resulting in a Na+/sugar ratio of 1.8 ± 0.1:1. This indicates a stoichiometry of 2:1, identical to that for rabbit SGLT1 measured by using the same methods (14), but different from the 1:1 stoichiometry reported for human (12) and rat (29) SGLT2. Those studies (12) compared the initial rate of [14C]alpha -MDG uptake with that of the Na+ influx calculated from the alpha -MDG-evoked inward current in a second oocyte, but they did not directly measure the Na+ influx. Assuming the current is completely carried by Na+, they concluded that the Na+-to-glucose coupling ratio for SGLT2 is 1:1. The Na-to-sugar stoichiometry of 2:1 means that SGLT3 has the same ability to concentrate sugar in the cell as SGLT1.

Once the stoichiometry is known, application of the Hill analysis can provide insights into the cooperativity of binding between the first and second Na+ sites (6, 22, 26). In our experiments the Hill coefficient (n) for SGLT3 was 1.6 ± 0.03, and it was voltage and substrate concentration independent, in agreement with the previous studies (1.3 at -70 mV; 15). In studies on SGLT1, n was found to range from 1.7 to 2.3 (21). This suggests that Na+ binding in SGLT1 has a higher degree of cooperatively between the Na+ binding sites than in SGLT3.

With the determination of the stoichiometry, the basic functional characterization of the three SGLTs is fairly complete and shows that SGLT3 has characteristics intermediately between SGLT1 and SGLT2 (Table 1). The sugar specifity is the same for SGLT2 and SGLT3 and different for SGLT1; so all three proteins transport D-glucose, but only SGLT1 also transports D-galactose and 3OMDG.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Summary of the characteristics of hSGLT1, hSGLT2, and pSGLT3

One of the criteria that has been used to distinguish the renal glucose cotransporters is sodium affinity. In 1982, Turner and Moran (24), in renal brush-border vesicles, were able to determine that for the high-affinity renal system the K0.5Na was 60 mM at 0.1 mM glucose, and for the low-affinity renal system the K0.5Na was 230 mM at 1 mM glucose, both at membrane voltage = 0 (25). We now know that the Na+ affinity for SGLT cotransporters is highly voltage and sugar concentration dependent (15, 21) and also depends on species (Table 2). Given the species, voltage-, and sugar-concentration dependence of the apparent sodium affinity, it is therefore not possible at present to definitively assign the low-affinity sugar transporter in the kidney to either SGLT2 or SGLT3 based on Na+ affinities. Given that inherited renal glycosuria, which is thought to be caused by a defect in the major renal SGLT (5, 6), has been assigned to human chromosome 6 by linkage analysis (2), it is likely that the gene coding for the renal low-affinity SGLT has yet to be identified.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Sodium affinity of Na+-sugar cotransporters

SGLT1 is similar to SGLT3 in its tissue distribution: SGLT1 is found in the rabbit intestinal epithelium (8) and in the inner renal cortex/outer medulla, by Northern analysis (20) and in situ hybridization (29). This tissue distribution suggests that the renal distribution of SGLT1 is confined to the S3 segment of the proximal tubule. Low levels of mRNA were detected in other tissues. SGLT2 mRNA was found in greatest abundance in the outer parts of the rat renal cortex and a weak signal in the intestine, but not in the liver, spleen, muscle, or brain (28), and in situ experiments indicated localization of SGLT2 to the S1 segment of the rat proximal tubule (12, 29). Functional assays also suggest a renal distribution of a low-affinity SGLT favoring the early proximal tubule in rabbits (20, 24, 25). On the other hand, SGLT3 RNA, which was cloned from the renal LLC-PK1 line, was most abundant in pig intestine followed by spleen, liver, kidney, and muscle (13).

Identification of the specific genetic defects in the SGLT1 protein that are the cause of the disease glucose-galactose malabsorption suggests a single functional SGLT exists in human intestine. Because genetic defects in SGLT1 are the cause of glucose and galactose malabsorption (19), it is unlikely that another glucose/galactose absorption pathway (e.g., SGLT3) with enough functional significance is present in the gut to compensate for the loss of SGLT1, so the functional significance of SGLT3 is unclear. However, there have been studies that have reported multiple human intestinal SGLTs. Malo (17, 18) described both high-affinity, low-capacity and low-affinity, high-capacity SGLTs in human fetal intestinal brush border. The differences in substrate specificities between these two cotransporters and their kinetics showed that in human fetal intestine, SLGT1 and a transporter similar to SGLT2 and SGLT3 coexist. This second transporter is developmentally regulated and is not expressed at birth. The identity of this transporter and its physiological role are still not known. When the human SGLT3 (4) becomes available for study, we anticipate new insights into the regulation, developmental biology, and function of glucose cotransporters. Comparison of the functional differences and similarities of these highly homologous proteins will help to elucidate the mechanism of cotransport.


    ACKNOWLEDGEMENTS

We thank Mary L. Bing for the isolation and preparation of the oocytes. This work was supported by National Institutes of Health Grants DK-19567, DK-44602, and GM-52094.


    FOOTNOTES

A. Díez-Sampedro is a recipient of a postdoctoral fellowship from the Departamento de Educación, Universidades e Investigación del Gobierno Vasco.

Address for reprint requests and other correspondence: B. A. Hirayama, Dept. of Physiology, UCLA School of Medicine, Los Angeles, CA 90095-1751 (Email: Bhirayama{at}mednet.ucla.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11 August 2000; accepted in final form 19 October 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1.   Barfuss, DW, and Schafer JA. Differences in active and passive glucose transport along the proximal nephron. Am J Physiol Renal Fluid Electrolyte Physiol 241: F322-F332, 1981[ISI][Medline].

2.   de Marchi, S, Cecchin E, Basile A, Proto G, Donadon W, Jengo A, Schinella D, Jus A, Villalta D, De Paoli P, Santini G, and Tesio F. Close genetic linkage between HLA and renal glycosuria. Am J Nephrol 4: 280-286, 1984[ISI][Medline].

3.   Diez-Sampedro, A, Lostao MP, Wright EM, and Hirayama BA. Glycoside binding and translocation in Na+-dependent glucose cotransporters: comparison of SGLT1 and SGLT3. J Membr Biol 176: 111-117, 2000[ISI][Medline].

4.   Dunham, I, Shimizu N, Roe BA, and Chissoe S. The DNA sequence of human chromosome 22. Nature 402: 489-495, 1999[ISI][Medline].

5.   Elsas, LJ, Hillman RE, Patterson JH, and Rosenberg LE. Renal and intestinal hexose transport in familial glucose-galactose malabsorption. J Clin Invest 49: 576-585, 1970[Medline].

6.   Elsas, LJ, and Rosenberg LE. Familial renal glycosuria: a genetic reappraisal of hexose transport by kidney and intestine. J Clin Invest 48: 1845-1854, 1969[ISI][Medline].

7.   Forster, IC, Loo DDF, and Eskandari S. Stoichiometry and Na+ binding cooperativity of rat and flounder renal type II Na+-Pi cotransporters. Am J Physiol Renal Physiol 276: F644-F649, 1999[Abstract/Free Full Text].

8.   Hediger, MA, Coady MJ, Ikeda TS, and Wright EM. Expression cloning and cDNA sequencing of the Na+/glucose co-transporter. Nature 330: 379-381, 1987[ISI][Medline].

9.   Hediger, MA, Turk E, and Wright EM. Homology of the human intestinal Na+/glucose and Escherichia coli Na+/proline cotransporters. Proc Natl Acad Sci USA 86: 5748-5752, 1989[Abstract].

10.   Hirayama, BA, Lostao MP, Panayotova-Heiermann M, Loo DD, Turk E, and Wright EM. Kinetic and specificity differences between rat, human, and rabbit Na+-glucose cotransporters (SGLT-1). Am J Physiol Gastrointest Liver Physiol 270: G919-G926, 1996[Abstract/Free Full Text].

11.   Ikeda, TS, Hwang ES, Coady MJ, Hirayama BA, Hediger MA, and Wright EM. Characterization of a Na+/glucose cotransporter cloned from rabbit small intestine. J Membr Biol 110: 87-95, 1989[ISI][Medline].

12.   Kanai, Y, Lee WS, You G, Brown D, and Hediger MA. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 93: 397-404, 1994[ISI][Medline].

13.   Kong, CT, Yet SF, and Lever JE. Cloning and expression of a mammalian Na+/amino acid cotransporter with sequence similarity to Na+/glucose cotransporters. J Biol Chem 268: 1509-1512, 1993[Abstract/Free Full Text].

14.   Mackenzie, B, Loo DDF, and Wright EM. Relationships between Na+/glucose cotransporter (SGLT1) currents and fluxes. J Membr Biol 162: 101-106, 1998[ISI][Medline].

15.   Mackenzie, B, Loo DDF, Panayotova-Heiermann M, and Wright EM. Biophysical characteristics of the pig kidney Na+/glucose cotransporter SGLT2 reveal a common mechanism for SGLT1 and SGLT2. J Biol Chem 271: 32678-32683, 1996[Abstract/Free Full Text].

16.   Mackenzie, B, Panayotova-Heiermann M, Loo DDF, Lever JE, and Wright EM. SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation. J Biol Chem 269: 22488-22491, 1994[Abstract/Free Full Text].

17.   Malo, C. Kinetic evidence for heterogeneity in Na+-D-glucose cotransport systems in the normal human fetal small intestine. Biochim Biophys Acta 938: 181-188, 1988[ISI][Medline].

18.   Malo, C. Separation of two distinct Na+/D-glucose cotransport systems in the human fetal jejunum by means of their differential specificity for 3-O-methylglucose. Biochim Biophys Acta 1022: 8-16, 1990[ISI][Medline].

19.   Martin, MG, Turk E, Lostao MP, Kerner C, and Wright EM. Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption. Nat Genet 12: 216-220, 1996[ISI][Medline].

20.   Pajor, AM, Hirayama BA, and Wright EM. Molecular biology approaches to comparative study of Na-glucose cotransport. Am J Physiol Regulatory Integrative Comp Physiol 263: R489-R495, 1992[Abstract/Free Full Text]. Review.

21.   Parent, L, Supplisson S, Loo DDF, and Wright EM. Electrogenic properties of the cloned Na+/glucose cotransporter: I. Voltage-clamp studies. J Membr Biol 125: 49-62, 1992[ISI][Medline].

22.   Segel, IH. Enzyme Kinetics. New York: Wiley-Interscience, 1975, p. 346-464.

23.   Turk, E, Zabel B, Mundlos S, Dyer J, and Wright EM. Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter. Nature 350: 354-356, 1991[ISI][Medline].

24.   Turner, RJ, and Moran A. Heterogeneity of sodium-dependent D-glucose transport sites along the proximal tubule, evidence from vesicle studies. Am J Physiol Renal Fluid Electrolyte Physiol 242: F406-F414, 1982[ISI][Medline].

25.   Turner, RJ, and Moran A. Stoichiometry studies of the renal outer cortical brush border membrane D-glucose transporter. J Membr Biol 67: 73-80, 1982b[ISI][Medline].

26.   Weiss, JN. The Hill equation revisited, uses and misuses. FASEB J 11: 835-841, 1997[Abstract/Free Full Text].

27.   Wells, RG, Mohandas TK, and Hediger MA. Localization of the Na+/glucose cotransporter gene SGLT2 to human chromosome 16 close to the centromere. Genomics 17: 787-789, 1993[ISI][Medline].

28.   Wells, RG, Pajor AM, Kanai Y, Turk E, Wright EM, and Hediger MA. Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Physiol Renal Fluid Electrolyte Physiol 263: F459-F465, 1992[Abstract/Free Full Text].

29.   You, G, Lee WS, Barros EJ, Kanai Y, Huo TL, Khawaja S, Wells RG, Nigam SK, and Hediger MA. Molecular characteristics of Na-coupled glucose transporters in adult and embryonic rat kidney. J Biol Chem 270: 29365-29371, 1995[Abstract/Free Full Text].


Am J Physiol Renal Fluid Electrolyte Physiol 280(2):F278-F282
0363-6127/01 $5.00 Copyright © 2001 the American Physiological Society